First Time Loading...

Certara Inc
NASDAQ:CERT

Watchlist Manager
Certara Inc Logo
Certara Inc
NASDAQ:CERT
Watchlist
Price: 16.21 USD -4.37% Market Closed
Updated: Apr 19, 2024

Intrinsic Value

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. [ Read More ]

The intrinsic value of one CERT stock under the Base Case scenario is 10.42 USD. Compared to the current market price of 16.21 USD, Certara Inc is Overvalued by 36%.

Key Points:
CERT Intrinsic Value
Base Case
10.42 USD
Overvaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Certara Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CERT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Certara Inc

Provide an overview of the primary business activities
of Certara Inc.

What unique competitive advantages
does Certara Inc hold over its rivals?

What risks and challenges
does Certara Inc face in the near future?

Has there been any significant insider trading activity
in Certara Inc recently?

Summarize the latest earnings call
of Certara Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Certara Inc.

Provide P/S
for Certara Inc.

Provide P/E
for Certara Inc.

Provide P/OCF
for Certara Inc.

Provide P/FCFE
for Certara Inc.

Provide P/B
for Certara Inc.

Provide EV/S
for Certara Inc.

Provide EV/GP
for Certara Inc.

Provide EV/EBITDA
for Certara Inc.

Provide EV/EBIT
for Certara Inc.

Provide EV/OCF
for Certara Inc.

Provide EV/FCFF
for Certara Inc.

Provide EV/IC
for Certara Inc.

Show me price targets
for Certara Inc made by professional analysts.

What are the Revenue projections
for Certara Inc?

How accurate were the past Revenue estimates
for Certara Inc?

What are the Net Income projections
for Certara Inc?

How accurate were the past Net Income estimates
for Certara Inc?

What are the EPS projections
for Certara Inc?

How accurate were the past EPS estimates
for Certara Inc?

What are the EBIT projections
for Certara Inc?

How accurate were the past EBIT estimates
for Certara Inc?

Compare the revenue forecasts
for Certara Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Certara Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Certara Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Certara Inc compared to its peers.

Compare the P/E ratios
of Certara Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Certara Inc with its peers.

Analyze the financial leverage
of Certara Inc compared to its main competitors.

Show all profitability ratios
for Certara Inc.

Provide ROE
for Certara Inc.

Provide ROA
for Certara Inc.

Provide ROIC
for Certara Inc.

Provide ROCE
for Certara Inc.

Provide Gross Margin
for Certara Inc.

Provide Operating Margin
for Certara Inc.

Provide Net Margin
for Certara Inc.

Provide FCF Margin
for Certara Inc.

Show all solvency ratios
for Certara Inc.

Provide D/E Ratio
for Certara Inc.

Provide D/A Ratio
for Certara Inc.

Provide Interest Coverage Ratio
for Certara Inc.

Provide Altman Z-Score Ratio
for Certara Inc.

Provide Quick Ratio
for Certara Inc.

Provide Current Ratio
for Certara Inc.

Provide Cash Ratio
for Certara Inc.

What is the historical Revenue growth
over the last 5 years for Certara Inc?

What is the historical Net Income growth
over the last 5 years for Certara Inc?

What is the current Free Cash Flow
of Certara Inc?

Financials

Balance Sheet Decomposition
Certara Inc

Current Assets 340.2m
Cash & Short-Term Investments 235m
Receivables 93.3m
Other Current Assets 12m
Non-Current Assets 1.2B
PP&E 12.3m
Intangibles 1.2B
Other Non-Current Assets 7.3m
Current Liabilities 130m
Accounts Payable 5.2m
Accrued Liabilities 41.7m
Other Current Liabilities 83.1m
Non-Current Liabilities 386.3m
Long-Term Debt 288.2m
Other Non-Current Liabilities 98.1m
Efficiency

Earnings Waterfall
Certara Inc

Revenue
354.3m USD
Cost of Revenue
-141m USD
Gross Profit
213.3m USD
Operating Expenses
-207.1m USD
Operating Income
6.2m USD
Other Expenses
-61.6m USD
Net Income
-55.4m USD

Free Cash Flow Analysis
Certara Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

CERT Profitability Score
Profitability Due Diligence

Certara Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
48/100
Profitability
Score

Certara Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

CERT Solvency Score
Solvency Due Diligence

Certara Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
High Altman Z-Score
55/100
Solvency
Score

Certara Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CERT Price Targets Summary
Certara Inc

Wall Street analysts forecast CERT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CERT is 20.12 USD with a low forecast of 15.66 USD and a high forecast of 24.15 USD.

Lowest
Price Target
15.66 USD
3% Downside
Average
Price Target
20.12 USD
24% Upside
Highest
Price Target
24.15 USD
49% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

CERT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

CERT Price
Certara Inc

1M 1M
-13%
6M 6M
+18%
1Y 1Y
-34%
3Y 3Y
-42%
5Y 5Y
-30%
10Y 10Y
-30%
Annual Price Range
16.21
52w Low
12.12
52w High
24.64
Price Metrics
Average Annual Return -4.31%
Standard Deviation of Annual Returns 44.11%
Max Drawdown -76%
Shares Statistics
Market Capitalization 2.7B USD
Shares Outstanding 160 191 008
Percentage of Shares Shorted 4.75%

CERT Return Decomposition
Main factors of price return

What is price return decomposition?

CERT News

Other Videos

Company Profile

Certara Inc Logo
Certara Inc

Country

United States of America

Industry

Health Care

Market Cap

2.7B USD

Dividend Yield

0%

Description

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. The company is headquartered in Princeton, New Jersey and currently employs 1,054 full-time employees. The company went IPO on 2020-12-11. The firm is focused on producing medicines for patients using biosimulation software and technology to transform traditional drug discovery and development. Biosimulation is a technology used to conduct virtual trials using virtual patients to better understand how drugs behave in different individuals. The firm builds its biosimulation technology on the first principles of biology, chemistry, and pharmacology with mathematical algorithms that model how medicines and diseases behave in the body. Its software and technology-enabled services include Mechanistic Biosimulation Platform (Simcyp); Empirical Pharmacokinetic and Pharmacodynamic Biosimulation (Phoenix); Scientific Informatics Platform (D360); Clinical Outcomes Databases for Biosimulation (CODEx); Authoring and Management of Regulatory Submissions Platform (GlobalSubmit), And Market Access Communication Platform (BaseCase).

Contact

NEW JERSEY
Princeton
100 Overlook Center, Suite 101
+16097167900.0
https://www.certara.com/

IPO

2020-12-11

Employees

1 054

Officers

CEO & Director
Dr. William F. Feehery Ph.D.
President & Chief Commercial Officer
Mr. Leif E. Pedersen
President of Certara Scientific Software
Dr. Robert P. Aspbury Ph.D.
President of Certara Drug Development Solutions
Dr. Patrick F. Smith Pharm.D.
Chief Financial Officer
Mr. John E. Gallagher III
Chief Technology Officer
Mr. Max Kanevsky
Show More
Chief Scientific Officer
Prof. Amin Rostami PharmD, Ph.D., FCP
Senior VP, General Counsel & Secretary
Mr. Richard M. Traynor
Senior Vice President of Corporate Development
Mr. Ron DiSantis
Chief Marketing Officer
Ms. Sheila Rocchio MBA
Show Less

See Also

Discover More
What is the Intrinsic Value of one CERT stock?

The intrinsic value of one CERT stock under the Base Case scenario is 10.42 USD.

Is CERT stock undervalued or overvalued?

Compared to the current market price of 16.21 USD, Certara Inc is Overvalued by 36%.